ClinicalTrials.gov
public full text
Public Domain
Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
This proposed study sets out to examine the antidepressant effects of tocilizumab among patients with treatment-refractory major depression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder#849292
- Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression#1137483
- Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)#1059547
- Duloxetine for Perimenopausal Depression#897078
- Comparison of Anodal Transcranial Direct Current Stimulation (t-DCS) and Sham Stimulation in Patients With Treatment-resistant Depression#901787
Record · ID 1173619
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive